Fabre kramer
Fabre kramer
Fabre Kramer Pharmaceuticals
Fabre-Kramer Pharmaceuticals, Inc.? 5847 San Felipe, Suite 2000? Houston, TX 77057 (713) 975-6900 ? Fax (713) 977-1574 Email contact: info@fabrekramer.com (more...)
Fabre-Kramer Pharmaceuticals, Inc.: Private Company Information ...
Get Fabre-Kramer Pharmaceuticals, Inc. company research & investing information. Find executive management and the latest company developments. (more...)
Healthcare Sales & Marketing Network News: Fabre-Kramer Re-Acquires ...
News, Information, Networking and Market Research for sales and marketing professionals in medical devices, pharmaceuticals and biotechnology: Fabre-Kramer Re-Acquires Gepirone ER ... (more...)
Fabre-Kramer Pharmaceuticals Inc, Houston, TX 77057
Get detailed business information on Fabre-Kramer Pharmaceuticals Inc in Houston TX 77057. Find phone number, driving directions and more. Search other Drugs And Toiletries ... (more...)
Fabre-Kramer refiles gepirone ER with the FDA for the treatment of ...
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates. (more...)
Fabre-Kramer refiles gepirone ER with the FDA for the treatment of ...
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates. (more...)
Fabre Kramer Pharmaceuticals receives FDA decision on Gepirone ER for ...
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug ... (more...)
Fabre Kramer Pharmaceuticals
Strategy. Our Philosophy. Founded in 1992 in Houston, Texas, Fabre-Kramer Pharmaceuticals focuses on compounds to license-in, develop for global ... (more...)
Fabre Kramer Pharmaceuticals receives decision from FDA on gepirone ER ...
This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates. (more...)
Fabre-Kramer re-acquires rights to gepirone ER from Organon
Privately held Fabre-Kramer Pharmaceuticals (drugs to treat neurological disorders) has agreed to buy back from Akzo Nobel 's human healthcare unit NV Organon development and ... (more...)